Mainz Biomed N.V. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.96M-0.59M-11.69M-26.39M-26.30M-21.65M
Share-based Compensation 6.43M9.82M4.01M1.14M
Gains from Investment Securities -0.66M2.05M
Asset Writedowns and Impairment 0.05M
Cash from Operations -0.42M-0.47M-3.22M-14.77M-21.94M-17.09M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.06M
Depreciation & Amortization (CF) 0.05M0.06M0.07M0.38M0.87M1.02M
Change in Working Capital
Change in Receivables 0.34M-0.10M0.02M-0.21M0.02M0.06M
Change in Inventory 0.17M0.50M-0.03M
Change in Account Payables 0.09M0.16M0.66M1.65M0.72M0.08M
Other Working Capital Changes 0.83M0.05M0.24M-0.01M
Investing Activities
Capital Expenditures 0.01M0.02M0.66M1.20M0.10M
Sales of Property, Plant and Equipment 0.02M
Cash from Investing Activities -0.01M1.20M-0.66M-1.90M-0.20M
Financing Activities
Cash from Financing Activities 0.42M0.40M10.61M23.94M14.23M16.60M
Dividend Payments
Dividends Paid - Preferred 0.00M
Additional items
Exchange Rate Effect -0.03M0.00M0.01M-0.10M-0.46M-0.15M
Change in Cash 0.01M-0.08M8.60M8.41M-10.07M-0.84M
Beginning Cash Balance 0.03M
Free Cash Flow -0.42M-0.48M-3.24M-15.43M-23.14M-17.19M
Net Cash Flow 0.01M-0.08M8.59M8.52M-9.61M-0.69M